+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carcinoma Drug"

Adrenocortical Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Adrenocortical Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
From
From
From
Head & Neck Carcinoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Head & Neck Carcinoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Transitional Cell Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Transitional Cell Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Thymic carcinoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Thymic carcinoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Neuroendocrine Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Neuroendocrine Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Loading Indicator

Carcinoma drugs are a type of oncology drug used to treat cancer. They are designed to target and destroy cancer cells while minimizing damage to healthy cells. Carcinoma drugs can be administered orally, intravenously, or topically, depending on the type of cancer being treated. Common types of carcinoma drugs include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Chemotherapy is a type of carcinoma drug that uses drugs to kill cancer cells. Targeted therapy is a type of drug that targets specific molecules in cancer cells, such as proteins or genes, to stop the growth and spread of cancer. Immunotherapy is a type of drug that helps the body’s immune system fight cancer. Hormone therapy is a type of drug that blocks hormones that can cause cancer cells to grow. The carcinoma drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. Other companies in the market include AstraZeneca, Eli Lilly, GlaxoSmithKline, and Sanofi. Show Less Read more